ShangRing

DEVICE5 trials

Sponsors

FHI 360, Weill Medical College of Cornell University, Jhpiego, IntraHealth International

Conditions

CircumcisionCircumcision, MaleDeformityMale CircumcisionPenile BleedingPenile HaematomaPenile Infection

Phase 1

Male Circumcision (MC) Using the ShangRing™ Device in Malawi

CompletedNCT02309710

FHI 360Male Circumcision

Start: 2015-06-30End: 2015-12-31Updated: 2016-01-21

Unknown Phase

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

CompletedNCT02242565

FHI 360Male Circumcision

Start: 2014-10-31End: 2015-12-31Updated: 2017-10-02

Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa

CompletedNCT03338699

Weill Medical College of Cornell UniversityCircumcision

Start: 2018-10-01End: 2020-12-18Updated: 2021-03-04

Evaluation and Adverse Event Surveillance for Initial Implementation of ShangRing Circumcision in Mozambique

WithdrawnNCT03761836

JhpiegoCircumcision, Male

Start: 2020-11-01End: 2021-12-30Updated: 2020-12-22

Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania

CompletedNCT06273696

IntraHealth InternationalDeformity, Penile Bleeding, Penile Haematoma +1

Start: 2019-05-01End: 2019-07-30Updated: 2024-02-22

Related Papers

Safety and efficacy of the ShangRing for early infant male circumcision in the routine clinical setting

BMJ Global Health2025-09-01

ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: a multicentre, non-inferiority, adaptive, randomised controlled trial.

2022-10-017 citations